Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
Open Access
- 1 September 1979
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 150 (3) , 445-454
- https://doi.org/10.1084/jem.150.3.445
Abstract
The dependence of antibody-and-complement-mediated lysis of virus-infected cells on the alternative pathway was examined utilizing the isolated cytolytic alternative pathway--a system consisting of the six purified proteins of the alternative pathway of activation (C3, factors B and D, beta 1H, C3b inactivator and properdin), and the five proteins of the membrane attack pathway (C5--9) of complement. HeLa cells acutely infected with measles virus were lysed by anti-viral IgG and the isolated cytolytic alternative pathway with an efficiency comparable to whole human serum. IgG and its F(ab')2 fragment were equally effective in inducing lysis by the isolated cytolytic alternative pathway, binding of approximately equal to 5 X 10(7) molecules per cell being required for 50% lysis; in contrast, no lysis occurred when equivalen or greater amounts of Fab' were bound to the virus-infected cell. Properdin was required for lysis. No lysis occurred if properdin was deleted from the isolated cytolytic alternative pathway, and lysis was diminished by 80% in properdin-depleted serum. Uptake of [125I]C3b from the isolated alternative pathway onto measles virus-infected cells occurred in the absence of properdin, but was accelerated in the presence of properdin. The 11 proteins of the isolated cytolytic alternative pathway are thus sufficient for lysis of measles virus-infected cells bearing anti-viral IgG or F(ab')2 without any other serum protein.This publication has 23 references indexed in Scilit:
- Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.The Journal of Experimental Medicine, 1979
- HUMAN ALTERNATIVE COMPLEMENT PATHWAY - MEMBRANE-ASSOCIATED SIALIC-ACID REGULATES THE COMPETITION BETWEEN B AND BETA-1H FOR CELL-BOUND C3B1979
- Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.Proceedings of the National Academy of Sciences, 1978
- Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cellsProceedings of the National Academy of Sciences, 1978
- Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsThe Journal of Experimental Medicine, 1977
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Activation of the alternative complement pathway due to resistance of zymosan-bound.Proceedings of the National Academy of Sciences, 1977
- Complement Activation by Measles Virus Cytotoxic Antibodies: Alternative Pathway C Activation by Hemagglutination-Inhibition Antibodies but Classical Activation by Hemolysin AntibodiesThe Journal of Immunology, 1977
- Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.The Journal of Experimental Medicine, 1976
- THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTSThe Journal of Experimental Medicine, 1965